No comments yet

The cost of emerging drugs: Quebec’s wrenching choices

No one could blame Noëlla Panneton for accusing the Quebec government of playing God. When she learned she had pancreatic cancer three years ago, she was denied coverage for a potentially life-saving chemotherapy treatment because at age 74, she wasn’t considered a good investment.

Post a comment

You must be logged in to post a comment.